Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

COMy Virtual 2020 | Kenneth Anderson: What are the next steps to a myeloma cure?

Kenneth Anderson • 4 May 2020
COMy Virtual 2020
Multiple Myeloma Rare Diseases Smoldering Myeloma Antibodies CAR-T

Kenneth Anderson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the next steps towards a cure in the myeloma field. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Kenneth Anderson

Defining high-risk myeloma in the era of immune therapies: progress made, unmet needs & more 13:45
Defining high-risk myeloma in the era of immune therapies: progress made, unmet needs & more
Francesco Maura et al. • 24 Oct 2025
Defining high-risk multiple myeloma: recent advances in the field & future considerations
Francesco Maura et al. • 4 Nov 2024
Collaboration in the myeloma community 1:27
Collaboration in the myeloma community
Kenneth Anderson • 14 May 2022
The future of myeloma treatment and the possibility of cure 4:04
The future of myeloma treatment and the possibility of cure
Kenneth Anderson • 14 May 2022

Related Videos

Integrating molecular diagnostics in smoldering myeloma to predict disease progression 1:37
Integrating molecular diagnostics in smoldering myeloma to predict disease progression
Gareth Morgan • 7 Dec 2025
Prolonged elranatamab treatment interruption in R/R myeloma: MagnetisMM-3 retrospective analysis 2:35
Prolonged elranatamab treatment interruption in R/R myeloma: MagnetisMM-3 retrospective analysis
Alexander Lesokhin • 8 Dec 2025
Integrated approaches to improve prognosis prediction in multiple myeloma 2:32
Integrated approaches to improve prognosis prediction in multiple myeloma
Claudio Cerchione • 6 Dec 2025
Using artificial intelligence to accelerate patient eligibility screening in clinical trials 1:52
Using artificial intelligence to accelerate patient eligibility screening in clinical trials
Aaron Gerds • 5 Dec 2025
The content of VJHemOnc is intended for healthcare professionals